The World Health Organization (WHO), as one of the founding members of Gavi and the UN's specialist agency providing leadership on global health issues, is a key policy influence and implementing partner.
WHO is one of four permanent members of the Gavi Board.
The UN agency's Department of Immunization, Vaccines and Biologicals, based at WHO headquarters in Geneva, supports and facilitates research and development, sets standards and regulates vaccine quality and develops evidence-based policy options to guide vaccine use and maximise country access.
As such, WHO sets down technical specifications for vaccines and prequalifies all vaccines that Gavi supports.
Gavi and its partners are guided by the recommendations of WHO's Vaccine Advisory Committee, vaccine position papers and the Immunization Practices Advisory Committee (IPAC). Set up in 2010 with many Gavi partners as members, IPAC advises on immunisation practices, operational standards, tools and technologies.
Since the Vaccine Alliance was founded in 2000, many more countries have followed WHO recommendations in introducing hepatitis B and Haemophilus influenzae type b vaccines as part of the pentavalent vaccine and, more recently, pneumococcal, rotavirus and human papillomavirus vaccines.
Gavi benefits from WHO input on issues ranging from cold chain and vaccine management, to training and post-introduction analysis of vaccines.
In the field, the Vaccine Alliance depends on collaboration with WHO's six regional offices and country offices present in all countries that receive Gavi support:
WHO offices also assist country health authorities in drafting applications for Gavi support and drawing up a plan of action for introducing vaccines.
In addition, WHO staff provide technical support to implementing immunisation programmes, including storage and logistics, as well as undertaking post-introduction monitoring and evaluation of vaccines and equipment.
There’s no heath for all without vaccines for all. WHO is proud to work with Gavi to ensure that all children, rich and poor, receive the same protection from vaccine-preventable diseases.